TEVA logo

Teva Pharmaceutical Industries Limited American Depositary Shares

TEVA

TEVA: Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the U.S. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a U.S.-based generic and specialty drug distributor.

more

Show TEVA Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of TEVA by members of U.S. Congress

Politician Type Traded
Greg Gianforte House / R Purchase $15,001 - $50,000 Nov. 13, 2020
Donna Shalala House / D Sale $1,001 - $15,000 May. 07, 2020
David E. Price House / D Sale $1,001 - $15,000 Jun. 19, 2019
Murray, Patty Senate / D Sale (Full) $1,001 - $15,000 Jun. 15, 2017
Cheri Bustos House / D Sale $1,001 - $15,000 Jan. 30, 2017
King, Angus Senate / I Sale (Full) $1,001 - $15,000 Oct. 19, 2016
K. Michael Conaway House / R Sale $1,001 - $15,000 Sep. 12, 2016
K. Michael Conaway House / R Sale $1,001 - $15,000 May. 11, 2016
K. Michael Conaway House / R Sale $1,001 - $15,000 May. 04, 2016
Alan S. Lowenthal House / D Sale $15,001 - $50,000 Sep. 11, 2015
Alan S. Lowenthal House / D Sale $15,001 - $50,000 Jul. 27, 2015
K. Michael Conaway House / R Sale $1,001 - $15,000 Feb. 09, 2015
Thomas Macarthur House / R Sale $1,001 - $15,000 Jan. 27, 2015
Thomas Macarthur House / R Purchase $1,001 - $15,000 Jan. 06, 2015
Alan S. Lowenthal House / D Purchase $15,001 - $50,000 Dec. 19, 2014
Alan S. Lowenthal House / D Purchase $15,001 - $50,000 Dec. 12, 2014
Mr. K. Michael Conaway House / R Sale $1,001 - $15,000 Mar. 12, 2014
Mr. K. Michael Conaway House / R Purchase $1,001 - $15,000 Mar. 06, 2014
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by TEVA's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $2,050,000 Apr 20, 2022 Issue: Health Issues
  • $600,000 Jan 20, 2022 Issue: HEALTH ISSUES
  • $700,000 Oct 25, 2021 Issue: HEALTH ISSUES
  • $810,000 Oct 25, 2021 Issue: HEALTH ISSUES
  • $1,820,000 Apr 20, 2021 Issue: HEALTH ISSUES
  • $610,000 Jan 21, 2021 Issue: HEALTH ISSUES
  • $500,000 Oct 19, 2020 Issue: HEALTH ISSUES
  • $580,000 Jul 16, 2020 Issue: None
  • $430,000 Apr 20, 2020 Issue: None
  • $410,000 Jan 21, 2020 Issue: None
  • $75,000 Jul 11, 2019 Issue: Pharmacy Health Issues
  • $30,000 Jul 05, 2019 Issue: Medicare/Medicaid Health Issues Pharmacy
  • $740,000 Jun 25, 2019 Issue: Health Issues Trade (domestic/foreign)
  • $700,000 Jan 21, 2019 Issue: Health Issues
  • $1,130,000 Jul 20, 2018 Issue: Health Issues
  • $480,000 Apr 20, 2018 Issue: Health Issues
  • $880,000 Jan 22, 2018 Issue: Health Issues Taxation/Internal Revenue Code
  • $1,200,000 Oct 19, 2017 Issue: Health Issues Taxation/Internal Revenue Code
  • $840,000 Jul 20, 2017 Issue: Health Issues Taxation/Internal Revenue Code
  • $2,670,000 Apr 20, 2017 Issue: Health Issues Taxation/Internal Revenue Code
  • $1,170,000 Jan 31, 2017 Issue: Pharmacy Trade (domestic/foreign) Copyright/Patent/Trademark
  • $30,000 Feb 09, 2016 Issue: Pharmacy
  • $45,000 Jan 28, 2016 Issue: Pharmacy
  • $900,000 Jan 20, 2016 Issue: Trade (domestic/foreign) Copyright/Patent/Trademark Pharmacy
  • $990,000 Oct 19, 2015 Issue: Pharmacy Trade (domestic/foreign) Copyright/Patent/Trademark
  • $980,000 Jul 16, 2015 Issue: Pharmacy Trade (domestic/foreign)
  • $1,200,000 Apr 19, 2015 Issue: Trade (domestic/foreign) Pharmacy
  • $890,000 Jan 20, 2015 Issue: Pharmacy Trade (domestic/foreign)
  • $880,000 Oct 20, 2014 Issue: Pharmacy Trade (domestic/foreign)
  • $870,000 Jul 21, 2014 Issue: Pharmacy Trade (domestic/foreign) Copyright/Patent/Trademark
  • $1,160,000 Apr 18, 2014 Issue: Pharmacy Copyright/Patent/Trademark Trade (domestic/foreign)
  • $800,000 Jan 17, 2014 Issue: Pharmacy Copyright/Patent/Trademark Trade (domestic/foreign)
  • $810,000 Oct 21, 2013 Issue: Pharmacy Copyright/Patent/Trademark Tariff (miscellaneous tariff bills) Trade (domestic/foreign)
  • $820,000 Jul 22, 2013 Issue: Tariff (miscellaneous tariff bills) Pharmacy Copyright/Patent/Trademark Trade (domestic/foreign)
  • $1,570,000 Apr 22, 2013 Issue: Pharmacy Trade (domestic/foreign) Copyright/Patent/Trademark Tariff (miscellaneous tariff bills)
  • $750,000 Jan 22, 2013 Issue: Pharmacy Copyright/Patent/Trademark Trade (domestic/foreign) Tariff (miscellaneous tariff bills)
  • $620,000 Oct 22, 2012 Issue: Pharmacy Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
  • $700,000 Jul 19, 2012 Issue: Pharmacy Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues
  • $970,000 Apr 20, 2012 Issue: Pharmacy Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues
  • $680,000 Jan 20, 2012 Issue: Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Pharmacy
  • $660,000 Oct 20, 2011 Issue: Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Pharmacy
  • $670,000 Jul 20, 2011 Issue: Health Issues Pharmacy Trade (domestic/foreign) Copyright/Patent/Trademark
  • $1,440,000 Apr 20, 2011 Issue: Pharmacy Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
  • $620,000 Jan 20, 2011 Issue: Pharmacy Copyright/Patent/Trademark Trade (domestic/foreign) Health Issues
  • $610,000 Oct 26, 2010 Issue: Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Pharmacy
  • $840,000 Jul 16, 2010 Issue: Pharmacy Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
  • $820,000 Apr 20, 2010 Issue: Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark Pharmacy
  • $780,000 Jan 20, 2010 Issue: Pharmacy Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
  • $770,000 Oct 20, 2009 Issue: Pharmacy Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
  • $840,000 Jul 16, 2009 Issue: Pharmacy Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
  • $950,000 Apr 20, 2009 Issue: Pharmacy Trade (domestic/foreign) Copyright/Patent/Trademark
  • $510,000 Jan 16, 2009 Issue: Pharmacy Medicare/Medicaid Copyright/Patent/Trademark Health Issues Trade (domestic/foreign) Budget/Appropriations
  • $570,000 Oct 20, 2008 Issue: Pharmacy Budget/Appropriations Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Medicare/Medicaid
  • $490,000 Jul 18, 2008 Issue: Pharmacy Health Issues Copyright/Patent/Trademark Budget/Appropriations Trade (domestic/foreign) Medicare/Medicaid
  • $640,000 Apr 29, 2008 Issue: Pharmacy Budget/Appropriations Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues Medicare/Medicaid
  • $1,160,000 Feb 14, 2008 Issue: Budget/Appropriations Copyright/Patent/Trademark Trade (domestic/foreign) Pharmacy Medicare/Medicaid
  • $1,100,000 Aug 14, 2007 Issue: Pharmacy Medicare/Medicaid Budget/Appropriations Trade (domestic/foreign) Copyright/Patent/Trademark
  • $680,000 Feb 14, 2007 Issue: Pharmacy Budget/Appropriations Copyright/Patent/Trademark Trade (domestic/foreign) Medicare/Medicaid
  • $600,000 Aug 03, 2006 Issue: Trade (domestic/foreign) Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Pharmacy
  • $740,000 Feb 14, 2006 Issue: Trade (domestic/foreign) Pharmacy Copyright/Patent/Trademark Medicare/Medicaid
  • $740,000 Aug 15, 2005 Issue: Trade (domestic/foreign) Copyright/Patent/Trademark Medicare/Medicaid Pharmacy
  • $360,000 Feb 14, 2005 Issue: Trade (domestic/foreign) Medicare/Medicaid Pharmacy
  • $340,000 Aug 16, 2004 Issue: Trade (domestic/foreign) Pharmacy Medical/Disease Research/Clinical Labs
  • $640,000 Feb 17, 2004 Issue: Medicare/Medicaid Pharmacy
  • $500,000 Aug 14, 2003 Issue: Pharmacy
  • $320,000 Feb 24, 2003 Issue: Medicare/Medicaid Pharmacy
  • $300,000 Aug 30, 2002 Issue: Pharmacy
  • $40,000 Mar 05, 2002 Issue: Health Issues
U.S. Patents

New patents grants

  • Patent Title: Medical injection device packaging May. 09, 2023
  • Patent Title: S1p3 antagonists Oct. 18, 2022
  • Patent Title: Injector pen Nov. 23, 2021
  • Patent Title: Medroxyprogesterone acetate injectable compositions and methods of use Oct. 05, 2021
  • Patent Title: Re-useable injector device for syringe Mar. 19, 2019
  • Patent Title: Analogs of pridopidine, their preparation and use Nov. 20, 2018
  • Patent Title: Re-useable injector device for syringe Sep. 11, 2018
  • Patent Title: Injector pen Aug. 28, 2018
  • Patent Title: S1p3 antagonists Apr. 24, 2018
  • Patent Title: Re-useable injector device for syringe Nov. 28, 2017
  • Patent Title: Process for manufacturing glatiramer acetate product Sep. 19, 2017
  • Patent Title: Process for manufacturing glatiramer acetate product Jul. 18, 2017
  • Patent Title: Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis Jun. 27, 2017
  • Patent Title: Laquinimod for the treatment of relapsing-remitting multiple sclerosis (rrms) patients with a high disability status May. 30, 2017
  • Patent Title: Dose counter and recording method Apr. 18, 2017
  • Patent Title: Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate Apr. 18, 2017
  • Patent Title: Respiratory apparatus Apr. 11, 2017
  • Patent Title: Respiratory apparatus Apr. 11, 2017
  • Patent Title: Biomarkers predictive for clinical response for glatiramer acetate Apr. 11, 2017
  • Patent Title: Respiratory apparatus Apr. 11, 2017
  • Patent Title: Respiratory apparatus Apr. 11, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory appartus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Treatment of bdnf-related disorders using laquinimod Mar. 07, 2017
  • Patent Title: Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate Nov. 22, 2016
  • Patent Title: Formulations of albu-bche, preparation and uses thereof Aug. 09, 2016
  • Patent Title: Formulations of 6-mercaptopurine Jun. 28, 2016
  • Patent Title: R(+)-n-formyl-propargyl-aminoindan May. 24, 2016
  • Patent Title: R(+)-n-methyl-propargyl-aminoindan May. 17, 2016
  • Patent Title: Stable laquinimod preparations May. 17, 2016
  • Patent Title: Parenteral formulations of rasagiline Apr. 12, 2016
  • Patent Title: N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereof Mar. 15, 2016
Government Contracts

Federal grants, loans, and purchases

WallStreetBets

Number of mentions of TEVA in WallStreetBets Daily Discussion

TEVA News

Recent insights relating to TEVA

CNBC Recommendations

Recent picks made for TEVA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in TEVA

Corporate Flights

Flights by private jets registered to TEVA